The recently published DIGAMI 2 randomized 1253 MI patients with hyperglycemia to 24 hour insulin-glucose infusion to obtain glucose levels between 7.0 and 10.0 mmol/L and subcutaneous long-term insulin treatment thereafter, to 24 hours glucose control followed by standard glucose control thereafter, or to standard glucose control started after admission [32]. This evidence concerns the gene INS and Hyperglycemia.